Cover Image
QR Code

Health Insurance, Pharmaceuticals, And More.

The article discusses various aspects of health insurance and pharmaceuticals as examined in the November issue of Health Affairs. Key findings include the high costs of employer-sponsored health insurance, with average family premiums at $25,572, and significant out-of-pocket expenses for Medicare...

Full description

Published in:Health Affairs Vol. 43; no. 11; pp. 1484 - 1485
Main Author: WEIL, ALAN R.
Format: editorial Journal Article
Published: Health Affairs Publishing, LLC Nov2024
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=190587882&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 190587882
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        02782715
        HAF
      jtl: Health Affairs
      issn: 02782715
      maglogo: N
    pubinfo:
      dt: Nov2024
      vid: 43
      iid: 11
      pid: 1453
      pub: Health Affairs Publishing, LLC
      place: Washington, District of Columbia
    artinfo:
      ui:
        190587882
        190587882
        190587882
        10.1377/hlthaff.2024.01360
        190587882
      ppf: 1484
      ppct: 1
      formats:
      tig:
        atl: Health Insurance, Pharmaceuticals, And More.
      aug:
        au: WEIL, ALAN R.
      sug:
        subj:
          Insurance Coverage
          Pharmaceutical Companies
          Health Insurance Exchanges
          Medicare
          Medicaid
          Health Care Costs
      ab: The article discusses various aspects of health insurance and pharmaceuticals as examined in the November issue of Health Affairs. Key findings include the high costs of employer-sponsored health insurance, with average family premiums at $25,572, and significant out-of-pocket expenses for Medicare enrollees, particularly in traditional Medicare compared to Medicare Advantage plans. The article also highlights the impact of Medicaid eligibility determinations post-COVID-19, the availability of dental coverage, and the implications of the Inflation Reduction Act on drug price negotiations. Additionally, it addresses the challenges in the adoption of immunization requirements across states.
      pubtype: Academic Journal
      doctype:
        editorial
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N